Clinical Trials
15 trialsNCT07401277 2026-04-22
Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
West Virginia University
Phase 1 Recruiting
NCT07144826 2026-02-13
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03756311 2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available
NCT04060628 2026-01-23
Expanded Access to NanoDoce
NanOlogy, LLC
No longer available
NCT04314895 2025-05-23
Trial of NanoPac Intratumoral Injection in Lung Cancer
NanOlogy, LLC
Phase 2 Completed
NCT03899077 2024-02-07
SAVE
Cancer Research Antwerp
Phase 2 Unknown
NCT05631028 2023-03-14
95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment
Shanghai Pulmonary Hospital, Shanghai, China
Phase NA Completed
NCT05435911 2023-01-13
Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol
Seoul National University Hospital
Phase NA Completed
NCT04221828 2022-03-29
Trial of NanoPac Focal Therapy for Prostate Cancer
NanOlogy, LLC
Phase 2 Terminated
NCT05023499 2021-08-26
Perioperative Glutamine Supplementation and Cachexia
National Taiwan University Hospital
Completed
NCT04260360 2020-08-04
Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma
NanOlogy, LLC
Phase 1 Withdrawn
NCT00989261 2019-12-11
ACE
Daiichi Sankyo
Phase 2 Completed
NCT01049893 2019-02-12
Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors
Daiichi Sankyo
Phase 1 Completed
NCT01481441 2016-07-06
AMC_2011_190
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Terminated
NCT01314599 2015-11-05
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
PharmaMar
Phase 1 Completed